NEW YORK, July 23 - NaPro BioTherapeutics has entered into a research agreement with North Dakota State University to apply its gene editing technology in the wheat genome project, the company said today.
The company said it will work with the university researchers to make single base-pair changes in wheat genes to improve crop traits. The work will help NaPro further develop this technology for agro-genomics applications, the company said.
The organizations did not disclose the financial terms of the agreement.
NaPro's gene editing technology uses oligonucleotides to locate, label, isolate, and modify a single base pair in an organism's gene, the company said. It is does not use foreign genetic material such as transgenes or plasmid vectors. The company, based in Boulder, Colo, develops natural product biopharmaceuticals, and develops and licenses genomics technologies for agriculture, pharmacogenomics, diagnostics, and therapeutics.